Entity
  • AELIX Therapeutics

    Created in 2014
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    235 2,916
  • Activities

  • Technologies

  • Entity types

  • Location

    Carrer de Baldiri Reixac, 4, 08028 Barcelona, Spain

    Barcelona

    Spain

  • Employees

    Scale: 2-10

    Estimated: 6

  • Engaged corporates

    2
    1 1
  • Added in Motherbase

    5 years, 3 months ago
Description
  • Value proposition

    Developing novel vaccines to cure HIV infection

    AELIX Therapeutics is a clinical-stage biotechnology company based in Barcelona, Spain. It is focused on the development of a therapeutic HIV vaccine to be included in cure/eradication strategies. AELIX Therapeutics is a spin-off of HIVACAT, the Catalan public-private consortium conducting cutting-edge research in this field. AELIX holds a worldwide, exclusive license for the development and commercialization of the HTI immunogen.

Corporate interactions BETA
Corporate TypeTweets Articles
CaixaBank
CaixaBank
Bank, Banking
CaixaBank
Bank, Banking
Other

10 Jul 2019


Gilead Sciences
Gilead Sciences
Pharmaceutical, Biotechnology, Biotechnology Research
Gilead Sciences
Pharmaceutical, Biotechnology, Biotechnology Research
Not capitalistic
Partnership
Not event

18 Oct 2018


Similar entities
Loading...
Loading...
Social network dynamics